Live feed08:52:23·725dSECFilingvia QuantisnowCoherus BioSciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.CHRS· Coherus Oncology Inc.Health CareOriginal source
